Enhanced Tumor-Targeted Delivery of Arginine-Rich Peptides via a Positive Feedback Loop Orchestrated by
Minghai Ma1, Xing Li2, Minxuan Jing1
1Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Department of Urology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.
Abstract:
Peptide-based drugs hold great potential for cancer treatment, and their effectiveness is driven by mechanisms on how peptides target cancer cells and escape from potential lysosomal entrapment post-endocytosis. Yet, the mechanisms remain elusive, which hinder the design of peptide-based drugs. Here hendeca-arginine peptides (R11) are synthesized for targeted delivery in bladder carcinoma (BC), investigated the targeting efficiency and elucidated the mechanism of peptide-based delivery, with the aim of refining the design and efficacy of peptide-based therapeutics. It is demonstrated that the over-activated Piezo1/integrin β1 (ITGB1) signaling axis significantly facilitates tumor-targeted delivery of R11 peptides via macropinocytosis. Furthermore, R11 peptides formed hydrogen bonds with integrin β1, facilitating targeting and penetration into tumor cells. Additionally, R11 peptides protected integrin β1 from lysosome degradation, promoting its recycling from cytoplasm to membrane. Moreover, this findings establish a positive feedback loop wherein R11 peptides activate Piezo1 by increasing membrane fusion, promoting Ca2+ releasing and resulting in enhanced integrin β1-mediated endocytosis in both orthotopic models and clinical tissues, demonstrating effective tumor-targeted delivery. Eventually, the Piezo1/integrin β1 signaling axis promoted cellular uptake and transport of peptides, establishing a positive feedback loop, promoting mechanical delivery to cancer and offering possibilities for drug modification in cancer therapy.
Insights
Hendeca-arginine peptides (R11) target bladder cancer by engaging the Piezo1/integrin β1 axis. This interaction enhances cellular uptake and prevents lysosomal degradation, improving peptide drug delivery for cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Peptide-based drugs offer promise for cancer treatment but their precise targeting mechanisms remain unclear.
- Lysosomal entrapment can limit the efficacy of peptide therapeutics.
- Understanding these mechanisms is crucial for designing effective peptide-drug conjugates.
Purpose of the Study:
- To synthesize hendeca-arginine peptides (R11) for targeted delivery in bladder carcinoma (BC).
- To investigate the targeting efficiency and elucidate the mechanism of R11 peptide delivery.
- To refine the design and efficacy of peptide-based therapeutics.
Main Methods:
- Synthesis of hendeca-arginine peptides (R11).
- Investigation of R11 peptide targeting in bladder carcinoma models.
- Elucidation of the Piezo1/integrin β1 signaling pathway's role in R11 uptake.
- Analysis of R11 peptide interactions with integrin β1 and lysosomal pathways.
Main Results:
- The Piezo1/integrin β1 signaling axis significantly facilitates R11 peptide tumor targeting via macropinocytosis.
- R11 peptides form hydrogen bonds with integrin β1, enhancing tumor cell targeting and penetration.
- R11 peptides protect integrin β1 from lysosomal degradation, promoting its recycling.
- A positive feedback loop involving R11, Piezo1, and integrin β1 enhances cellular uptake and transport.
Conclusions:
- The Piezo1/integrin β1 axis is a key mediator of R11 peptide tumor-targeted delivery.
- R11 peptides promote their own uptake and transport through a positive feedback mechanism.
- These findings offer new strategies for modifying peptide drugs to enhance cancer therapy efficacy.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...


